1. Deloménie C, Fouix S, Longuemaux S, Brahimi N, Bizet C, Picard B et al . Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid J Bacteriol 2001 183: 3417–3427
2. Upton A, Johnson N, Sandy J, Sim E . Arylamine N-acetyltransferases—of mice, men and microorganisms Trends Pharmacol Sci 2001 22: 140–146
3. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH et al . Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms Cancer Epidemiol Biomarkers Prev 2000 9: 29–42
4. Cascorbi I, Roots I, Brockmoller J . Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10 Cancer Res 2001 61: 5051–5056
5. Geylan YS, Dizbay S, Guray T . Arylamine N-acetyltransferase activities in human breast cancer tissues Neoplasma 2001 48: 108–111